β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

0

Alzheimer’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in met…

Read More...

Leave A Reply